CALCA and migraine disorder: Predictive factors for being a "good responder" to ubrogepant included migraine with aura, episodic migraine, <5 prior unsuccessful preventive or acute treatments, successful responses to a CGRP monoclonal antibody and onabotulinumtoxinA.